WordNet

PrepTutorEJDIC

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.

Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman-Boon PC, Mannaerts BM.Source1st Department of Obstetrics and Gynaecology, Papageorgiou Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Reproductive biomedicine online.Reprod Biomed Online.2012 Apr;24(4):410-9. doi: 10.1016/j.rbmo.2012.01.005. Epub 2012 Jan 24.
Corifollitropin alfa is a novel recombinant gonadotrophin with sustained follicle-stimulating activity. A single injection can replace seven daily injections of recombinant follicle-stimulating hormone (rFSH) during the first week of ovarian stimulation. All cases of ovarian hyperstimulation syndrom
PMID 22386594

[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].

Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Brüske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hübner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H; German Respiratory Society; German Cancer Society.SourceInstitut für Theoretische Chirurgie, Universitätsklinikum Marburg, Germany. GGoeckenjan@t-online.de
Pneumologie (Stuttgart, Germany).Pneumologie.2011 Aug;65(8):e51-75. doi: 10.1055/s-0030-1256562. Epub 2011 Aug 9.
PMID 21830177

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.

Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.SourceDepartment of Obstetrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany. griesing@uni-luebeck.de
Fertility and sterility.Fertil Steril.2011 May;95(6):2029-33, 2033.e1. doi: 10.1016/j.fertnstert.2011.01.163. Epub 2011 Mar 2.
OBJECTIVE: To prospectively study ovarian hyperstimulation syndrome (OHSS) incidence and cumulative live birth rate in a cohort of patients at risk of OHSS undergoing ovarian stimulation in a GnRH antagonist protocol and receiving a GnRH agonist triggering followed by cryopreservation of all two pro
PMID 21371705

A RECOVERED CASE OF THROMBOSIS OF SINUS TRANSVERSUS AND GLOMUS VENOSUS JUGULI BY GRUNERT'S OPERATION

市原正雄,宮尾赳
昭和医学会雑誌 15(5), 351-353, 1955
… The case, however, had been given treatment under a mis-diagnosis of Griesinger's syndrome, and was completely cured by Grunert's operation. …
NAID 130001820388